10x Genomics
TXG
TXG
85 hedge funds and large institutions have $2.35B invested in 10x Genomics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
4% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 27
8% less funds holding
Funds holding: 92 → 85 (-7)
Holders
85
Holding in Top 10
5
Calls
$5.9M
Puts
$2.68M
Top Buyers
| 1 | +$40.9M | |
| 2 | +$38.1M | |
| 3 | +$23.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$12.1M |
Top Sellers
| 1 | -$29.9M | |
| 2 | -$27M | |
| 3 | -$7.56M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$6.42M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.92M |